Bangladesh, Oct. 27 -- The country's leading drug maker Square Pharmaceuticals has reported a 15.54 per cent year-on-year growth in profit to Tk 27.70 billion in FY26, driven by a significant rise in revenue.

Company officials said their efforts to keep manufacturing unaffected even during the power shortage played a significant role in ensuring higher revenue. The achievement was possible through a combination of energy sources: the national grid and power generated from diesel and solar.

"We faced no power outage and continued production uninterrupted," said Muhammad Zahangir Alam, chief financial officer (CFO) of Square Pharmaceuticals.

Square Pharma's supply chain is also broad, delivering products to people across the country, wh...